Literature DB >> 24008120

Simultaneous quantification of Kirenol and ent-16β,17-dihydroxy-kauran-19-oic acid from Herba Siegesbeckiae in rat plasma by liquid chromatography-tandem mass spectrometry and its application to pharmacokinetic studies.

Linan Huo1, Zhen Jiang, Ming Lei, Xintao Wang, Xingjie Guo.   

Abstract

A rapid and specific liquid chromatography-electrospray ionization-tandem mass spectrometry (LC-ESI-MS/MS) method was developed for the simultaneous determination of two active diterpenoids: Kirenol and ent-16β,17-dihydroxy-kauran-19-oic acid (DHKA) from Herba Siegesbeckiae in rat plasma using osthole as an internal standard (IS). Plasma sample pretreatment involved a one-step liquid-liquid extraction with ethyl acetate. Chromatographic separation was performed on a Waters Symmetry C18 column (2.1mm×100mm, 3.5μm) with isocratic elution using methanol-5mmol/L aqueous ammonium acetate (80:20, v/v) as the mobile phase at a flow rate of 0.2mL/min. The detection was performed on a triple quadrupole tandem mass spectrometer in multiple reaction monitoring (MRM) mode under positive and negative electrospray ionization. The calibration curves were linear over the range of 50.0-25,000ng/mL for Kirenol, and 25.0-12,500ng/mL for DHKA. The extraction recoveries of the two analytes and the IS were all over 85%. The intra- and inter-day precision (relative standard deviation) values were less than 16.8% and the accuracy (relative error) ranged from -10.7 to 10.6% at four quality control levels. The validated method was successfully applied to a comparative pharmacokinetic study of the two diterpenoids in rat plasma after intragastric administration of Kirenol, DHKA and Herba Siegesbeckiae extract. The results showed that there were obvious differences between the pharmacokinetic behaviors after oral administration of Herba Siegesbeckiae extract compared with each of the substances alone.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Herba Siegesbeckiae; Kirenol; LC-ESI–MS/MS; Pharmacokinetics; ent-16β,17-dihydroxy-kauran-19-oic acid

Mesh:

Substances:

Year:  2013        PMID: 24008120     DOI: 10.1016/j.jchromb.2013.08.019

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  5 in total

1.  [Kirenol relieves dextran sulfate sodium-induced ulcerative colitis in mice by inhibiting inflammatory cytokines and inducing CD4+ T lymphocyte apoptosis].

Authors:  Liu Xiuhong; D U Yajun; Liu Guoxing; Dan Guomei; Tong Xin; Xiao Juan
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-12-30

2.  Kirenol Inhibits the Function and Inflammation of Fibroblast-like Synoviocytes in Rheumatoid Arthritis in vitro and in vivo.

Authors:  Jing Wu; Qiang Li; Li Jin; Yuan Qu; Bi-Bo Liang; Xiao-Tong Zhu; Hong-Yan Du; Li-Gang Jie; Qing-Hong Yu
Journal:  Front Immunol       Date:  2019-06-06       Impact factor: 7.561

3.  Protective Effects of Kirenol against Lipopolysaccharide-Induced Acute Lung Injury through the Modulation of the Proinflammatory NFκB Pathway and the AMPK2-/Nrf2-Mediated HO-1/AOE Pathway.

Authors:  Frank Cheau-Feng Lin; Shiuan-Shinn Lee; Yi-Ching Li; Yung-Chuan Ho; Wen-Ying Chen; Chun-Jung Chen; Min-Wei Lee; Kun-Lin Yeh; Stella Chin-Shaw Tsai; Yu-Hsiang Kuan
Journal:  Antioxidants (Basel)       Date:  2021-01-31

Review 4.  Kirenol: A Potential Natural Lead Molecule for a New Drug Design, Development, and Therapy for Inflammation.

Authors:  Naurah Nabihah Nasir; Mahendran Sekar; Shivkanya Fuloria; Siew Hua Gan; Nur Najihah Izzati Mat Rani; Subban Ravi; M Yasmin Begum; Kumarappan Chidambaram; Kathiresan V Sathasivam; Srikanth Jeyabalan; Arulmozhi Dhiravidamani; Lakshmi Thangavelu; Pei Teng Lum; Vetriselvan Subramaniyan; Yuan Seng Wu; Abul Kalam Azad; Neeraj Kumar Fuloria
Journal:  Molecules       Date:  2022-01-23       Impact factor: 4.411

5.  Kirenol attenuates experimental autoimmune encephalomyelitis by inhibiting differentiation of Th1 and th17 cells and inducing apoptosis of effector T cells.

Authors:  Juan Xiao; Rongbing Yang; Lin Yang; Xiaohang Fan; Wenwei Liu; Wenbin Deng
Journal:  Sci Rep       Date:  2015-03-12       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.